Zepbound for Sleep Apnea: Coverage and Who Qualifies

Will insurance cover Zepbound for sleep apnea? Many plans do, if you have moderate to severe obstructive sleep apnea (OSA) and obesity. The FDA approved Zepbound for OSA on December 20, 2024, so many plans that exclude weight-loss drugs will consider it for sleep apnea. Medicare Part D plans can cover it, and state Medicaid programs must cover it for OSA. Expect prior authorization: plans typically ask for a sleep study showing an apnea-hypopnea index (AHI) of 15 or more, a BMI of 30 or higher, and often proof that CPAP didn't work or isn't an option. Without coverage, Lilly's self-pay price is $449 a month at the doses used for sleep apnea when you refill on time, as of November 2026.

Two things to know before you read on. First, compounded tirzepatide is not FDA-approved for sleep apnea or for anything else, it was not studied in the sleep apnea trials, and insurance doesn't cover it. Second, MaxLife does not diagnose or treat sleep apnea. If you have, or think you have, sleep apnea, the right route is a doctor, a sleep study and brand Zepbound with coverage, which is what this guide is about. If you're separately looking for weight management and plan to pay cash, the last section explains where compounded tirzepatide fits.

Is Zepbound FDA-Approved for Sleep Apnea?

Yes. Zepbound (tirzepatide) is FDA-approved "to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity," together with a reduced-calorie diet and more physical activity, according to its prescribing information (revised August 2026). When the FDA approved it on December 20, 2024, it called Zepbound "the first drug treatment option for certain patients with obstructive sleep apnea." Zepbound is also approved for chronic weight management.

Zepbound is a once-weekly injection. Treatment starts at 2.5 mg for 4 weeks, and the dose goes up in 2.5 mg steps at least 4 weeks apart. For sleep apnea, the label's maintenance dose is 10 mg or 15 mg once a week.

Mounjaro contains tirzepatide too, but it is approved for type 2 diabetes, not sleep apnea. The sleep apnea trials excluded people with type 2 diabetes. Wegovy (semaglutide) is not approved for sleep apnea either, as of November 2026.

Do you have to try CPAP first?

Not under the FDA approval. One of the two trials enrolled people who were unable or unwilling to use positive airway pressure (PAP), and the other enrolled people already using it, so the label doesn't require you to fail CPAP first. Many insurance plans do require a CPAP history, as you'll see below.

Zepbound doesn't replace CPAP by default. The FDA calls PAP "the standard of care for moderate to severe OSA," and the label notes that the trials "did not evaluate the timing or appropriateness of PAP discontinuation" in people who were using PAP. Don't stop your CPAP unless your sleep doctor tells you to.

How Does Tirzepatide Help Sleep Apnea?

Tirzepatide helps sleep apnea mainly by reducing body weight. Obstructive sleep apnea happens when the upper airway becomes blocked during sleep, causing pauses in breathing, and it is more common in people with overweight or obesity. The FDA explains that Zepbound activates receptors for two gut hormones, GLP-1 and GIP, to reduce appetite and food intake, and that "by reducing body weight, studies show that Zepbound also improves OSA."

The evidence comes from the SURMOUNT-OSA trials, published in the New England Journal of Medicine in 2024. In two 52-week studies, 469 adults with moderate to severe OSA and obesity took Zepbound (10 mg or 15 mg) or a placebo. At the start, they averaged about 50 breathing events an hour. One study enrolled people not using PAP and the other people on PAP. The label reports these results at week 52:

"Remission or mild OSA without daytime sleepiness" means an AHI under 5, or an AHI of 5 to 14 with a score of 10 or less on the Epworth Sleepiness Scale, a daytime sleepiness questionnaire. People taking Zepbound also had larger drops in hypoxic burden (how much oxygen levels fall during sleep), systolic blood pressure and hsCRP, a marker of inflammation, and they reported less sleep-related impairment. These results come from brand Zepbound in clinical trials and have not been shown for compounded tirzepatide.

Side effects in the sleep apnea trials were similar to those in the weight trials. According to the label, nausea, diarrhea, vomiting and constipation are common, and most nausea, vomiting and diarrhea happened while the dose was being raised and decreased over time. Zepbound has a boxed warning about thyroid C-cell tumors seen in rats and should not be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Talk to your provider about your full health history. If daytime tiredness is a concern, our guide to whether tirzepatide makes you tired covers what the labels report.

How long does it take Zepbound to work for sleep apnea?

The trials measured their main result at 52 weeks, after a dose increase that took up to 20 weeks. Your doctor may repeat a sleep study to check progress. Some insurance plans require proof of improvement, such as a lower AHI or weight loss, before they renew coverage after the first 6 months.

How long do you have to take Zepbound for sleep apnea?

The label sets no end date, and the sleep apnea trials lasted 52 weeks. There is no published trial data on what happens to sleep apnea after stopping. Weight is the main driver of the benefit, and in a separate Zepbound weight trial, people who switched to placebo after 36 weeks saw their body weight rise 14% over the next 52 weeks, while those who stayed on Zepbound lost another 5.5%. Discuss any plan to stop with your doctor.

Will Insurance Cover Zepbound for Sleep Apnea?

Many plans cover Zepbound for sleep apnea, and a sleep apnea diagnosis can open coverage that a weight-loss exclusion would block. Many employer plans don't cover weight-loss drugs at all: only 18% of firms with 200 or more workers covered GLP-1 drugs for weight loss in 2026, according to KFF. Sleep apnea is a separate, FDA-approved use, and plans can treat it that way. UnitedHealthcare's 2026 policy, for example, says "Medications for the purpose of weight loss are typically a benefit exclusion. The program allows for coverage of Zepbound for obesity with obstructive sleep apnea" (UHC).

Coverage still depends on your plan, and some employer plans exclude Zepbound for every use. Here is how each type of coverage handles sleep apnea as of November 2026:

The fastest way to find out is to call the member services number on your card and ask: "Does my plan cover Zepbound for moderate to severe obstructive sleep apnea in an adult with obesity, and what are the prior authorization criteria?" For the wider picture on weight-loss drugs, see our guide to which weight loss drugs are covered by insurance.

What Do Insurers Require for Zepbound Prior Authorization?

Most plans that cover Zepbound for sleep apnea require prior authorization, meaning your prescriber must document that you meet the plan's criteria before it pays. The rules differ by plan, but three 2026 policies show the usual pattern: UnitedHealthcare's commercial policy (effective September 1, 2026), Oscar's clinical guideline and New Hampshire Medicaid's criteria (effective January 1, 2026).

Plans also exclude some situations. Oscar lists mild OSA (AHI under 15) as not medically necessary, UHC excludes predominantly central or mixed sleep apnea and planned sleep apnea or weight-loss surgery, and New Hampshire denies requests for weight management alone. If you don't know your BMI, our BMI calculator gives it in seconds; your prescriber will still need it documented in your chart.

Does Medicare Cover Zepbound for Sleep Apnea?

Yes, Medicare Part D plans can cover Zepbound for moderate to severe sleep apnea in adults with obesity. CMS lists type 2 diabetes, moderate to severe obstructive sleep apnea and a form of fatty liver disease (MASH) as uses that are "eligible for Part D coverage," and it names "Zepbound® for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity" as an example (CMS). Your plan applies its normal formulary and prior authorization rules. If Zepbound isn't on your plan's drug list, your prescriber can ask for a formulary exception; CMS tells plans to keep following their exception process for these requests.

What you pay depends on your plan's drug tiers. Medicare.gov describes the 2026 limits: after any deductible, you pay a share of the cost (25% coinsurance in the standard benefit) until your out-of-pocket spending on covered drugs reaches $2,100 for the year, and after that you pay nothing for covered Part D drugs for the rest of the year. The cap rises to $2,400 in 2027.

Can you use the Medicare GLP-1 Bridge for sleep apnea?

No. The Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027 and charges $50 a month for the Zepbound KwikPen, is for weight management only. CMS says people with moderate to severe obstructive sleep apnea "are ineligible to receive them through the Medicare GLP-1 Bridge," and that this holds "regardless of whether their current Part D plan covers a GLP-1 drug for that condition." Medicare.gov says the same and adds that "your Part D plan might cover your GLP-1s." Lilly's savings card can't be used with Medicare either, because government beneficiaries are excluded.

Does Medicaid Cover Zepbound for Sleep Apnea?

Yes. State Medicaid programs can choose whether to cover drugs for weight loss, but coverage is required for drugs approved for other conditions, and that has included "moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)" since December 2024, according to KFF. Expect prior authorization. New Hampshire's criteria above are one example; your state's preferred drug list or Medicaid plan will have its own.

How Much Does Zepbound for Sleep Apnea Cost Without Insurance?

Without coverage, Zepbound for sleep apnea costs $449 a month through LillyDirect at the 10 mg and 15 mg maintenance doses, as of November 2026. Lilly's self-pay prices for vials and KwikPens are:

Needles or syringes cost extra. If you have commercial insurance that doesn't cover Zepbound, Lilly's savings card can bring the single-dose pen to as low as $499 a month and the KwikPen to $299 to $449; with commercial coverage that includes Zepbound, it can be as little as $25 a fill. Lilly says the card "expires and savings end on 12/31/2026" (Lilly). HSA and FSA funds can usually pay for prescribed medicines, because IRS Publication 502 counts them as medical expenses. Our guide to tirzepatide cost compares every price, with and without insurance.

How to Get Zepbound Covered for Sleep Apnea

Getting Zepbound covered for sleep apnea comes down to a diagnosis on paper and a prescription written for that use. These steps give you the best chance:

1. Get evaluated. Signs of sleep apnea include loud snoring, gasping for air, breathing that starts and stops, and daytime sleepiness, according to the NHLBI. Your provider may refer you to a sleep specialist.
2. Do a sleep study. It confirms the type of sleep apnea and its severity. Plans want an AHI of 15 or more for Zepbound.
3. Check your plan's criteria. Ask for the written prior authorization criteria for Zepbound for OSA, including any CPAP, BMI, diabetes or prescriber requirements.
4. Ask your prescriber to submit for sleep apnea. The request should list the OSA diagnosis, the sleep study, your BMI and your CPAP history, so it isn't judged under a weight-loss exclusion.
5. Appeal a denial. Most private plans must decide a prior authorization within 15 days. You have 180 days to file an internal appeal and 4 months after a final denial to ask for an external review (HealthCare.gov). A letter from your sleep doctor that answers the exact denial reason helps.
6. Know your fallback. If coverage doesn't come through, LillyDirect self-pay is the FDA-approved option without insurance.

Can Compounded Tirzepatide Treat Sleep Apnea?

No. Compounded tirzepatide is not FDA-approved for sleep apnea or for any other use, which means the FDA hasn't reviewed it for safety, effectiveness or quality. It is prepared by a licensed pharmacy for one patient's prescription, and it is not Zepbound. The SURMOUNT-OSA results above come from brand Zepbound and have not been shown for compounded tirzepatide. Insurance doesn't cover compounded medicines, so it can't help with sleep apnea coverage either. Tirzepatide sold online "for research use only" isn't a safe route either; see what the FDA says about research peptides.

The FDA's own guidance points to the brand here. The FDA says compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug" (FDA), and for moderate to severe OSA with obesity, an FDA-approved drug exists.

MaxLife does not diagnose or treat sleep apnea. If you snore loudly, wake up gasping or feel sleepy during the day, talk to your doctor about a sleep study. If you already have a diagnosis, keep working with your sleep doctor, and ask about brand Zepbound and your coverage.

Paying Cash for Weight Management: Where MaxLife Fits

This section is for a different need: weight management when you plan to pay cash, not treatment for sleep apnea. For that, compounded tirzepatide through MaxLife is one option.

MaxLife is a telehealth patient management platform, not a pharmacy. You complete an online intake that takes about 2 minutes, and an independent licensed provider reviews it, usually within 24 hours, to decide whether a prescription for weight management is right for you. If it is, a licensed partner pharmacy prepares and dispenses your compounded tirzepatide, with free expedited shipping. It costs $120 a month, flat, the same price at every dose, with no membership fee, and the provider's review and follow-up, the medicine if prescribed, and supplies included. No insurance is needed, and HSA and FSA funds may be eligible. MaxLife is LegitScript certified and available in all 50 states.

Compounded tirzepatide is not FDA-approved, and it is not a treatment for sleep apnea. If you have sleep apnea or think you might, tell the provider during your intake and keep your sleep doctor involved. MaxLife's providers consider everything in your health record and decide case by case. If your insurance covers Zepbound for OSA, that is usually the better route. To compare cash-pay options side by side, see our guide to GLP-1 treatment without insurance.